Lipid and lipoprotein profiles in youth with and without type 1 diabetes: the SEARCH for Diabetes in Youth case-control study - PubMed (original) (raw)
Lipid and lipoprotein profiles in youth with and without type 1 diabetes: the SEARCH for Diabetes in Youth case-control study
John Guy et al. Diabetes Care. 2009 Mar.
Abstract
Objective: The purpose of this study was to compare the lipid profile and the prevalence of lipid abnormalities in youth with and without type 1 diabetes and explore the role of glycemic control on the hypothesized altered lipid profile in youth with type 1 diabetes.
Research design and methods: We conducted a cross-sectional analysis of 512 youth with type 1 diabetes (mean duration 4.22 years) and 188 healthy control subjects aged 10-22 years in Colorado and South Carolina. SEARCH for Diabetes in Youth (SEARCH) participants with type 1 diabetes and healthy control subjects recruited from primary care offices in the same geographic regions were invited to attend a research visit. Fasting lipid profiles were compared between youth with type 1 diabetes (stratified according to categories of optimal [A1C <7.5%] and suboptimal [A1C >or=7.5%] glycemic control) and healthy nondiabetic youth, using multiple linear and logistic regression.
Results: Youth with type 1 diabetes and optimal A1C had lipid concentrations that were similar (total cholesterol, LDL cholesterol, and LDL particle size) or even less atherogenic (HDL cholesterol, non-HDL cholesterol, triglyceride, and triglyceride-to-HDL cholesterol ratio) than those observed in nondiabetic youth, whereas youth with suboptimal glycemic control had elevated standard lipid levels (total cholesterol, LDL cholesterol, and non-HDL cholesterol). Youth with type 1 diabetes also had significantly elevated apolipoprotein B levels and more small, dense LDL particles than nondiabetic youth, regardless of glycemic control.
Conclusions: Youth with type 1 diabetes have abnormal lipid levels and atherogenic changes in lipoprotein composition, even after a relatively short disease duration. As in adults, glycemic control is an important mediator of these abnormalities.
Figures
Figure 1
Prevalence of abnormal lipid concentrations, adjusted for age, sex, and race/ethnicity in nondiabetic youth, youth with type 1 diabetes in optimal (A1C <7.5%), and suboptimal (A1C ≥7.5%) glycemic control. *P < 0.05, type 1 diabetes with optimal or suboptimal A1C versus healthy youth. +P < 0.01, type 1 diabetes with optimal or suboptimal A1C versus healthy youth.
Similar articles
- Serum lipids and glucose control: the SEARCH for Diabetes in Youth study.
Petitti DB, Imperatore G, Palla SL, Daniels SR, Dolan LM, Kershnar AK, Marcovina S, Pettitt DJ, Pihoker C; SEARCH for Diabetes in Youth Study Group. Petitti DB, et al. Arch Pediatr Adolesc Med. 2007 Feb;161(2):159-65. doi: 10.1001/archpedi.161.2.159. Arch Pediatr Adolesc Med. 2007. PMID: 17283301 - Lipid and lipoprotein levels in patients with IDDM diabetes control and complication. Trial experience. The DCCT Research Group.
[No authors listed] [No authors listed] Diabetes Care. 1992 Jul;15(7):886-94. doi: 10.2337/diacare.15.7.886. Diabetes Care. 1992. PMID: 1516509 Clinical Trial. - Adverse effects of obesity on lipid and lipoprotein levels in insulin-dependent and non-insulin-dependent diabetes.
Laakso M, Pyörälä K. Laakso M, et al. Metabolism. 1990 Feb;39(2):117-22. doi: 10.1016/0026-0495(90)90062-h. Metabolism. 1990. PMID: 2299984 - Diabetic dyslipidemia.
Kreisberg RA. Kreisberg RA. Am J Cardiol. 1998 Dec 17;82(12A):67U-73U; discussion 85U-86U. doi: 10.1016/s0002-9149(98)00848-0. Am J Cardiol. 1998. PMID: 9915665 Review. - Dyslipidemias in patients with diabetes mellitus: classification and risks and benefits of therapy.
Oki JC. Oki JC. Pharmacotherapy. 1995 May-Jun;15(3):317-37. Pharmacotherapy. 1995. PMID: 7667166 Review.
Cited by
- Single nucleotide polymorphism rs7961894, platelet morphological parameters and lipid profile in children with type 1 diabetes: a potential relationship.
El-Hawy MA, Abdelsattar S, Bedair HM, Elsaady DZ, Hola ASA. El-Hawy MA, et al. Eur J Pediatr. 2024 Oct;183(10):4385-4395. doi: 10.1007/s00431-024-05694-1. Epub 2024 Aug 5. Eur J Pediatr. 2024. PMID: 39098887 Free PMC article. - High-Density Lipoprotein Particle Concentration and Size Predict Incident Coronary Artery Disease Events in a Cohort With Type 1 Diabetes.
Costacou T, Vaisar T, Miller RG, Davidson WS, Heinecke JW, Orchard TJ, Bornfeldt KE. Costacou T, et al. J Am Heart Assoc. 2024 Jul 16;13(14):e034763. doi: 10.1161/JAHA.123.034763. Epub 2024 Jul 3. J Am Heart Assoc. 2024. PMID: 38958152 Free PMC article. - Imbalance of APOB Lipoproteins and Large HDL in Type 1 Diabetes Drives Atherosclerosis.
Kothari V, Ho TWW, Cabodevilla AG, He Y, Kramer F, Shimizu-Albergine M, Kanter JE, Snell-Bergeon J, Fisher EA, Shao B, Heinecke JW, Wobbrock JO, Lee WL, Goldberg IJ, Vaisar T, Bornfeldt KE. Kothari V, et al. Circ Res. 2024 Jul 5;135(2):335-349. doi: 10.1161/CIRCRESAHA.123.323100. Epub 2024 Jun 3. Circ Res. 2024. PMID: 38828596 Free PMC article. - Assessment of Nutrients Intake in Pediatrics with Type 1 Diabetes and Dyslipidemia in Jordan.
Tayyem R, Nawaiseh H, Zakarneh SB, Khial Y, Allehdan S. Tayyem R, et al. Adolesc Health Med Ther. 2024 Mar 19;15:31-43. doi: 10.2147/AHMT.S439046. eCollection 2024. Adolesc Health Med Ther. 2024. PMID: 38529360 Free PMC article. - A multi-centre investigation of macrovascular and non-ocular microvascular complications in children and adolescents with diabetes mellitus in southern Ghana.
Akpalu J, Essuman VA, Amoaku WM, Abaidoo B, Essuman A, Hayfron-Benjamin C, Barnes NA, Tagoe NN, Asare G, Ndanu TA, Appiah-Thompson B, Ofori-Adjei ID, Sackey AH. Akpalu J, et al. Ghana Med J. 2023 Jun;57(2):87-96. doi: 10.4314/gmj.v57i2.2. Ghana Med J. 2023. PMID: 38504754 Free PMC article.
References
- Cleeman JI, Grundy SM, Becker D, Clark LT, Cooper RS, Denke MA, Howard WJ, Hunninghake DB, Illingworth DR, Luepker RV, McBride P, McKenney JM, Pasternak RC, Stone NJ, Van Horn L, Brewer HB, Ernst ND, Gordon D, Levy D, Rifkind B, Rossouw JE, Savage P, Haffner SM, Orloff DG, Proschan MA, Schwartz JS, Sempos CT, Shero ST, Murray EZ: Executive summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 285:2486–2497, 2001 - PubMed
- Krolewski AS, Kosinski EJ, Warram JH, Leland OS, Busick EJ, Asmal AC, Rand LI, Christlieb AR, Bradley RF, Kahn CR: Magnitude and determinants of coronary artery disease in juvenile-onset, insulin-dependent diabetes mellitus. Am J Cardiol 59:750–755, 1987 - PubMed
- Berenson GS, Wattigney WA, Tracy RE, Newman WP, Srinivasan SR, Webber LS, Dalferes ER, Strong JP: Atherosclerosis of the aorta and coronary arteries and cardiovascular risk factors in persons aged 6 to 30 years and studied at necropsy (the Bogalusa Heart Study). Am J Cardiol 70:851–858, 1992 - PubMed
- Weis U, Turner B, Gibney J, Watts GF, Burke V, Shaw KM, Cummings MH: Long-term predictors of coronary artery disease and mortality in type 1 diabetes. Q J Med 94:623–630, 2001 - PubMed
- Wadwa RP, Kinney GL, Maahs DM, Snell-Bergeon J, Hokanson JE, Garg SK, Eckel RH, Rewers M: Awareness and treatment of dyslipidemia in young adults with type 1 diabetes. Diabetes Care 28:1051–1056, 2005 - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials